ArticleFunctional & integrative genomics2026
CircDCAF6 promotes myoblast differentiation by inhibiting the ubiquitination of ACTC1.
Article in Functional & integrative genomics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This study aims to investigate the role and molecular mechanism of the circular RNA circDCAF6, which is specifically highly expressed in the muscle tissue of Qinchuan cattle, during myoblast differentiation. Through cell experiments, it was found that the expression level of circDCAF6 first increased and then decreased during myoblast differentiation. Overexpression of circDCAF6 significantly promoted myotube formation and the expression of myogenic differentiation marker genes, while knockdown of circDCAF6 inhibited differentiation. RNA pull-down and mass spectrometry analysis identified ACTC1 as an interacting protein of circDCAF6. circDCAF6 promotes myogenic differentiation by inhibiting the ubiquitination modification of ACTC1, thereby maintaining its stability. Further research revealed that the ubiquitin ligase TRIM28 is a target protein of ACTC1 and participates in the regulation of ACTC1 ubiquitination by circDCAF6. This study elucidates the regulatory mechanism of the “circDCAF6-ACTC1-TRIM28” signaling axis in myogenic differentiation, provides new insights into the role of circRNA in muscle development regulation, Provide new insights into the regulation of muscle development and offer potential clues for future breeding research.
Indexed as
Identifiers
41699346What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.